111 related articles for article (PubMed ID: 10050706)
1. Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia.
Marsh JC; Chowdry J; Parry-Jones N; Ellis SW; Muir KR; Gordon-Smith EC; Tucker GT
Br J Haematol; 1999 Feb; 104(2):266-70. PubMed ID: 10050706
[TBL] [Abstract][Full Text] [Related]
2. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.
Griese EU; Ilett KF; Kitteringham NR; Eichelbaum M; Powell H; Spargo RM; LeSouef PN; Musk AW; Minchin RF
Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032
[TBL] [Abstract][Full Text] [Related]
3. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes.
Abdel-Rahman SZ; Salama SA; Au WW; Hamada FA
Pharmacogenetics; 2000 Apr; 10(3):239-49. PubMed ID: 10803680
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer.
Lee HC; Yoon YB; Kim CY
Korean J Intern Med; 1997 Jun; 12(2):128-36. PubMed ID: 9439147
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance.
Rannug A; Alexandrie AK; Persson I; Ingelman-Sundberg M
J Occup Environ Med; 1995 Jan; 37(1):25-36. PubMed ID: 7620940
[TBL] [Abstract][Full Text] [Related]
6. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
7. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
8. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
9. Correlation of CpG Island Methylation of the Cytochrome P450 2E1/2D6 Genes with Liver Injury Induced by Anti-Tuberculosis Drugs: A Nested Case-Control Study.
Zhang J; Zhu X; Li Y; Zhu L; Li S; Zheng G; Ren Q; Xiao Y; Feng F
Int J Environ Res Public Health; 2016 Aug; 13(8):. PubMed ID: 27490558
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
Muñoz S; Vollrath V; Vallejos MP; Miquel JF; Covarrubias C; Raddatz A; Chianale J
Pharmacogenetics; 1998 Aug; 8(4):343-51. PubMed ID: 9731721
[TBL] [Abstract][Full Text] [Related]
11. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
12. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis.
Kimura Y; Selmi C; Leung PS; Mao TK; Schauer J; Watnik M; Kuriyama S; Nishioka M; Ansari AA; Coppel RL; Invernizzi P; Podda M; Gershwin ME
Hepatology; 2005 Jan; 41(1):55-63. PubMed ID: 15690482
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
Huang YS; Chern HD; Su WJ; Wu JC; Chang SC; Chiang CH; Chang FY; Lee SD
Hepatology; 2003 Apr; 37(4):924-30. PubMed ID: 12668988
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
Neafsey P; Ginsberg G; Hattis D; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6 and CYP2E1 Gene Polymorphisms and their Association with Cervical Cancer Susceptibility: A Hospital Based Case-Control Study from South-Western Maharashtra.
Datkhile KD; Durgawale PP; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2591-2597. PubMed ID: 36037111
[TBL] [Abstract][Full Text] [Related]
20. CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians.
Agúndez JA; Rodríguez I; Olivera M; Ladero JM; García MA; Ribera JM; Benítez J
Age Ageing; 1997 Mar; 26(2):147-51. PubMed ID: 9177672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
